BRPI0611956A2 - composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto - Google Patents

composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto

Info

Publication number: BRPI0611956A2
Authority: BR; Brazil
Prior art keywords: compound; preparing; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2005-06-11

Application number

BRPI0611956A

Other languages

English (en)

Inventor

Philip Green Clive

John Butlin Roger

Mccoull William

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-11

Filing date

2006-06-06

Publication date

2018-07-31

2005-06-11 Priority claimed from GB0511851A external-priority patent/GB0511851D0/en

2005-09-16 Priority claimed from GB0518924A external-priority patent/GB0518924D0/en

2006-06-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2018-07-31 Publication of BRPI0611956A2 publication Critical patent/BRPI0611956A2/pt

Links

150000001875 compounds Chemical class 0.000 title 2
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)

BRPI0611956A 2005-06-11 2006-06-06 composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto BRPI0611956A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0511851A GB0511851D0 (en)	2005-06-11	2005-06-11	Chemical compounds
GB0518924A GB0518924D0 (en)	2005-09-16	2005-09-16	Chemical compounds
PCT/GB2006/002067 WO2006134317A1 (en)	2005-06-11	2006-06-06	Oxadiazole derivatives as dgat inhibitors

Publications (1)

Publication Number	Publication Date
BRPI0611956A2 true BRPI0611956A2 (pt)	2018-07-31

Family

ID=36764622

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0611956A BRPI0611956A2 (pt)	2005-06-11	2006-06-06	composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto

Country Status (11)

Country	Link
US (1)	US20090215779A1 (pt)
EP (1)	EP1893592A1 (pt)
JP (1)	JP2008543747A (pt)
KR (1)	KR20080015113A (pt)
AU (1)	AU2006258917A1 (pt)
BR (1)	BRPI0611956A2 (pt)
CA (1)	CA2610188A1 (pt)
IL (1)	IL187451A0 (pt)
MX (1)	MX2007015759A (pt)
NO (1)	NO20076066L (pt)
WO (1)	WO2006134317A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7795283B2 (en) *	2004-12-14	2010-09-14	Astrazeneca Ab	Oxadiazole derivative as DGAT inhibitors
US7749997B2 (en) *	2005-12-22	2010-07-06	Astrazeneca Ab	Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors
EP2402320A1 (en)	2006-03-31	2012-01-04	Novartis AG	Anorectic agents
JP2009538892A (ja) *	2006-05-30	2009-11-12	アストラゼネカアクチボラグ	アセチル補酵素ａジアシルグリセロールアシルトランスフェラーゼの阻害薬としての置換５−フェニルアミノ−１，３，４−オキサジアゾール−２−イルカルボニルアミノ−４−フェノキシ−シクロヘキサンカルボン酸
WO2007138304A1 (en)	2006-05-30	2007-12-06	Astrazeneca Ab	1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
JP2009539816A (ja) *	2006-06-06	2009-11-19	アストラゼネカアクチボラグ	化学化合物
ES2359653T3 (es) *	2006-06-08	2011-05-25	Astrazeneca Ab	Bencimidazoles y su uso para el tratamiento de la diabetes.
JP2010500300A (ja)	2006-08-08	2010-01-07	サノフィ−アベンティス	アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
WO2008099221A1 (en) *	2007-02-15	2008-08-21	Prosidion Limited	Amide and urea derivatives for the treatment of metabolic diseases
US8115011B2 (en)	2007-05-22	2012-02-14	Madrigal Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
US8153644B2 (en)	2007-05-22	2012-04-10	Madrigal Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
AU2008253118B2 (en) *	2007-05-22	2013-11-21	Madrigal Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
US8058299B2 (en)	2007-05-22	2011-11-15	Via Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
AU2008258560C1 (en)	2007-06-08	2014-04-10	Janssen Pharmaceutica N.V.	Piperidine/piperazine derivatives
JO2972B1 (en)	2007-06-08	2016-03-15	جانسين فارماسوتيكا ان. في	Piperidine / piperazine derivatives
ES2536406T3 (es) *	2007-06-08	2015-05-25	Janssen Pharmaceutica, N.V.	Derivados de piperidina/piperazina
ES2558152T3 (es)	2007-06-08	2016-02-02	Janssen Pharmaceutica, N.V.	Derivados de piperidina/piperazina
WO2009024821A2 (en) *	2007-08-17	2009-02-26	Astrazeneca Ab	Oxadiazole derivatives as dgat inhibitors
AR066169A1 (es)	2007-09-28	2009-07-29	Novartis Ag	Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
EP2234978B1 (en)	2007-12-20	2015-02-25	AstraZeneca AB	Carbamoyl compounds as dgat1 inhibitors 190
CA2716599A1 (en) *	2008-02-25	2009-09-03	Lars Thore Burgdorf	Glucokinase activators
ES2617619T3 (es) *	2008-06-05	2017-06-19	Janssen Pharmaceutica, N.V.	Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR
WO2010003624A2 (en)	2008-07-09	2010-01-14	Sanofi-Aventis	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
US8211884B2 (en)	2008-08-06	2012-07-03	Madrigal Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
US8324385B2 (en)	2008-10-30	2012-12-04	Madrigal Pharmaceuticals, Inc.	Diacylglycerol acyltransferase inhibitors
WO2010065310A1 (en)	2008-12-03	2010-06-10	Via Pharmaceuticals, Inc	Inhibitors of diacylglycerol acyltransferase
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
AU2009333333A1 (en)	2008-12-17	2011-06-30	Via Pharmaceuticals, Inc	Inhibitors of diacylglycerol aclytransferase
BRPI0924669A2 (pt) *	2008-12-19	2016-01-26	Astrazeneca Ab	composto, uso de um composto, método para tratar a diabete melito e/ou obesidade, e, composição farmacêutica
FR2941457A1 (fr) *	2009-01-28	2010-07-30	Sanofi Aventis	Derives de thiadiazoles et d'oxadiazoles leur preparation et leur application en therapeutique
NZ594244A (en)	2009-01-28	2013-07-26	Sanofi Sa	Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
EP2805951B1 (en)	2009-03-20	2018-03-14	Metabasis Therapeutics, Inc.	Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
SG174504A1 (en)	2009-03-27	2011-10-28	Bristol Myers Squibb Co	Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
BRPI1016109A2 (pt) *	2009-06-19	2016-05-17	Astrazeneca Ab	"composto, composição farmacêutica, e, processo para preparar um composto"
MX2012001729A (es)	2009-08-26	2012-06-13	Sanofi Sa	Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
CA2779948A1 (en)	2009-11-05	2011-05-12	Piramal Life Sciences Limited	Carboxy oxazole or thiazole compounds as dgat-1 inhibitors useful for the treatment of obesity
WO2012120052A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de)	2011-03-08	2015-04-22	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683699B1 (de)	2011-03-08	2015-06-24	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2013055910A1 (en)	2011-10-12	2013-04-18	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2892896B1 (en)	2012-09-05	2016-06-29	Bristol-Myers Squibb Company	Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
EP2892897A1 (en)	2012-09-05	2015-07-15	Bristol-Myers Squibb Company	Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
EP2903985A1 (en) *	2012-10-03	2015-08-12	Advinus Therapeutics Limited	Spirocyclic compounds, compositions and medicinal applications thereof
WO2014074668A1 (en)	2012-11-08	2014-05-15	Arena Pharmaceuticals, Inc.	Modulators of gpr119 and the treatment of disorders related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3245989A (en) *	1962-12-15	1966-04-12	Acraf	3-aminophenyl-5-aminoloweralkyl-1, 2, 4-oxadiazoles
RS20050019A (sr) *	2002-07-12	2007-09-21	Sanofi - Aventis Pharma Deutschland Gmbh.,	Heterociklično supstituisani benzoilkarbamidi,postupak za njihovu proizvodnju i njihova primena kao leka
KR100772297B1 (ko) *	2002-11-22	2007-11-02	니뽄 다바코 산교 가부시키가이샤	융합 비시클릭 질소-함유 헤테로사이클
AR044152A1 (es) *	2003-05-09	2005-08-24	Bayer Corp	Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad

2006
- 2006-06-06 KR KR1020077029752A patent/KR20080015113A/ko not_active Withdrawn
- 2006-06-06 JP JP2008515280A patent/JP2008543747A/ja active Pending
- 2006-06-06 BR BRPI0611956A patent/BRPI0611956A2/pt not_active IP Right Cessation
- 2006-06-06 MX MX2007015759A patent/MX2007015759A/es unknown
- 2006-06-06 EP EP06744121A patent/EP1893592A1/en not_active Withdrawn
- 2006-06-06 AU AU2006258917A patent/AU2006258917A1/en not_active Abandoned
- 2006-06-06 CA CA002610188A patent/CA2610188A1/en not_active Abandoned
- 2006-06-06 WO PCT/GB2006/002067 patent/WO2006134317A1/en not_active Ceased
- 2006-06-06 US US11/917,027 patent/US20090215779A1/en not_active Abandoned
2007
- 2007-11-18 IL IL187451A patent/IL187451A0/en unknown
- 2007-11-26 NO NO20076066A patent/NO20076066L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20080015113A (ko)	2008-02-18
CA2610188A1 (en)	2006-12-21
IL187451A0 (en)	2008-02-09
MX2007015759A (es)	2008-02-21
US20090215779A1 (en)	2009-08-27
JP2008543747A (ja)	2008-12-04
EP1893592A1 (en)	2008-03-05
WO2006134317A8 (en)	2008-02-21
WO2006134317A1 (en)	2006-12-21
NO20076066L (no)	2008-01-07
AU2006258917A1 (en)	2006-12-21

Legal Events

Date	Code	Title	Description
2011-11-22	B06G	Technical and formal requirements: other requirements [chapter 6.7 patent gazette]	Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.
2018-07-24	B06H	Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 6.7 NA RPI NO 2133 DE 22/11/2011 POR TER SIDO INDEVIDA.
2018-08-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-11-27	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0611956A2 (pt)	2018-07-31	composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
BRPI0816331A2 (pt)	2015-04-14	Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0821676A2 (pt)	2015-06-16	Composto, composição farmacêutica, e, processo para a preparação dos compostos.
BRPI0814611A2 (pt)	2015-01-27	Composição, processo para preparar uma composição, e, uso de uma composição
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI1006162A2 (pt)	2019-09-24	"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0816553A2 (pt)	2017-07-18	"composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto"
BRPI0618904A2 (pt)	2016-09-13	composto, composição farmacêutica, e, uso do composto
BRPI0811712A2 (pt)	2014-11-04	"composto, processo de preparação de um composto e composição farmacéutica".
BRPI0609802A2 (pt)	2017-05-02	composto, composição farmacêutica e uso de um composto
BRPI0614205A2 (pt)	2016-11-22	composto, composição farmacêutica, e, uso de composto
BRPI0813237A2 (pt)	2014-12-23	Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
PT1896065E (pt)	2011-08-31	Processo para a preparação de vacinas
BRPI0910734A2 (pt)	2015-09-29	composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0807807A2 (pt)	2014-06-17	" composição farmacêutica de liberação modificada e um processo para fabricar a mesma ".
BRPI0612254A2 (pt)	2016-09-06	composto, formulação farmacêutica, combinação, e, processo para preparar um composto
BRPI0720530A2 (pt)	2014-02-04	Partícula, processo para preparar a partícular, e, composição
BRPI0906475A2 (pt)	2015-07-14	Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI0811275A2 (pt)	2014-12-23	Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0908252A2 (pt)	2015-07-21	Processo para preparar um composto, e, uso de um composto
BRPI0607423A2 (pt)	2016-11-08	forma microcristalina de um composto, processo para a preparação da mesma, uso de uma forma microcristalina, composição farmacêutica e processo para a preparação da mesma, e, produto
BRPI0815360A2 (pt)	2015-02-10	Composto derivado de 4-pirimidinossulfamida, composição farmacêutica que o contem, uso e processo para pa preparação do composto
BRPI0908738A2 (pt)	2017-06-13	composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0814821A2 (pt)	2015-02-03	Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0815493A2 (pt)	2015-02-10	Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto.